0001104659-18-058108.txt : 20180924 0001104659-18-058108.hdr.sgml : 20180924 20180924085811 ACCESSION NUMBER: 0001104659-18-058108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180920 FILED AS OF DATE: 20180924 DATE AS OF CHANGE: 20180924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heberlig Chris CENTRAL INDEX KEY: 0001532217 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 181082711 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 a4.xml 4 X0306 4 2018-09-20 0 0001730430 Kiniksa Pharmaceuticals, Ltd. KNSA 0001532217 Heberlig Chris C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 BERMUDA 0 1 0 0 EVP & CFO Share Option 30.93 2018-09-20 4 A 0 45000 0 A 2028-09-19 Class A Common Shares 45000 45000 D The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three-year period thereafter. The vesting commencement date is September 20, 2018. /s/ Thomas W. Beetham, Attorney-in-Fact For Chris Heberlig 2018-09-24